Log on / register
Feedback | Support | My details
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors.
Hatano M, Kuwashima N, Tatsumi T, Dusak JE, Nishimura F, Reilly KM, Storkus WJ, Okada H
J Transl Med 2004 Nov 24, 2:40
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
Eph receptors in breast cancer: roles in tumor promotion and tumor suppression
Vaught D, Brantley-Sieders DM, Chen J
Breast Cancer Research 2008, 10:217 (22 December 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research    
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Zhu X, Nishimura F, Sasaki K, Fujita M, Dusak JE, Eguchi J, Fellows-Mayle W, Storkus WJ, Walker PR, Salazar AM, Okada H
Journal of Translational Medicine 2007, 5:10 (12 February 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 2 articles in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.